• Investing Ideas
  • /
  • Global Pharmaceuticals & Biotech Large Cap High Growth Potential
Header cover image

Global Pharmaceuticals & Biotech Large Cap High Growth Potential

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

56 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
A302440SK bioscienceLtd₩230,500.00-1.9%n/a₩17.6t₩346,666.67PE128.9xE76.0%n/a
300601Shenzhen Kangtai Biological ProductsCN¥105.03-1.9%-40.2%CN¥72.2bCN¥204.43PE95.4xE43.8%0.6%
300896Imeik Technology DevelopmentLtdCN¥624.007.8%159.4%CN¥135.0bCN¥772.90PE157.3xE40.5%0.3%
NVAXNovavaxUS$166.250.5%62.9%US$12.4bUS$264.20PS10.5xE69.2%n/a
661Changchun High & New Technology Industry (Group)CN¥277.80-6.0%-24.7%CN¥112.4bCN¥492.12PE30.7xE23.8%0.3%
3692Hansoh Pharmaceutical GroupHK$20.00-3.4%-44.2%HK$118.4bHK$37.84PE37.1xE22.6%0.4%
603392Beijing Wantai Biological Pharmacy EnterpriseCN¥235.406.1%81.5%CN¥142.9bCN¥339.11PE123.8xE32.7%0.08%
HZNPHorizon TherapeuticsUS$112.95-0.2%44.0%US$25.5bUS$133.00PE49.2xE57.6%n/a
GMABGenmabkr.2,852.004.5%23.7%kr.186.5bkr.2,799.96PE74.2xE36.0%n/a
2821Asymchem Laboratories (Tianjin)CN¥399.08-3.1%44.8%CN¥96.8bCN¥415.96PE115.8xE31.1%0.2%
2269WuXi Biologics (Cayman)HK$114.902.5%72.2%HK$487.5bHK$156.26PE144.3xE29.5%n/a
TXG10x GenomicsUS$154.09-1.2%-5.5%US$17.1bUS$196.38PS42.1xE52.9%n/a
300142Walvax BiotechnologyCN¥57.63-0.5%1.8%CN¥90.3bn/aPE71.6xE26.7%0%
INCYIncyteUS$64.58-0.4%-26.4%US$14.3bUS$99.00PE42.2xE36.1%n/a
AZNAstraZenecaUK£86.99-3.4%7.3%UK£134.8bUK£100.86PE49xE24.9%2.3%
1801Innovent BiologicsHK$77.751.9%19.9%HK$113.5bHK$95.08PS19.6xE71.4%n/a
688363Bloomage BioTechnologyCN¥172.00-6.4%28.3%CN¥82.6bCN¥257.41PE111.7xE31.8%0.2%
ALNYAlnylam PharmaceuticalsUS$203.90-0.3%45.0%US$24.2bUS$189.40PS35.2xE69.6%n/a
300759Pharmaron BeijingCN¥192.68-1.9%78.8%CN¥145.4bCN¥200.74PE121.6xE26.6%0.2%
603259WuXi AppTecCN¥143.701.3%63.4%CN¥423.6bCN¥185.18PE108.6xE29.7%0.2%
SGENSeagenUS$171.976.1%-13.2%US$31.3bUS$186.50PE52.4xE70.2%n/a
DIMSartorius Stedim Biotech€471.609.2%52.3%€43.5b€444.33PE91.5xE14.2%0.1%
ILMNIlluminaUS$410.531.5%27.8%US$64.2bUS$455.29PE83.5xE30.2%n/a
BMYBristol-Myers SquibbUS$56.94-0.8%-6.3%US$126.5bUS$74.73PS2.9xE25.8%3.4%
Page 1 of 3